← Oncology Approval Tracker

FDA DECISION ·

Zepzelca + Tecentriq or Tecentriq Hybreza

lurbinectedin + atezolizumab or atezolizumab and hyaluronidase-tqjs · Jazz Pharmaceuticals and Genentech

FDA approvalNew or expanded indicationSmall cell lung cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

As maintenance for adults with extensive-stage SCLC without progression after first-line induction with carboplatin, etoposide, and atezolizumab or atezolizumab and hyaluronidase-tqjs.

LAMPGEN ANALYSIS

Why it matters

IMforte supported adding lurbinectedin to checkpoint therapy as maintenance after a defined induction regimen.

What research teams should watch

Track the final induction assessment, verify the maintenance eligibility window, and coordinate blood count monitoring.

PRIMARY RECORDS

Sources